Document Zn828j49jwqg2Lo1y0EG8jm60

RSCYCLEO [S O 000223 )> /Wf ~9VVW From: To: Barbara J Dawson on 10/19/2000 12:06 PM Beth F Basham/AE/DuPortt@DuPont, Aaron Chen/AE/DuPont@DuPont, Michaei J Daly/AG/DuPont@DuPont, Nicholas J DeStefano/AE/DuPont@DuPont. Mary Arm Hayes/DuPont@DuPont, James R Koterski/AE/DuPont@DuPont, Irene A Legiec/AE/DuPont@DuPont, Richard J Libutti/DuPont@DuPont, Douglas A Paine/AE/DuPont@DuPont, Michael L 3zeo/AE/DuPont@DgPont Subject C8 Medical Surveillance - Draft Letter to Participants Here Is a copy of the letter we plan to send to participants a s approved b; ------- -- _ Forwarded by Barbara 4 Dawson/AH/DuPont on 10/19/200012:04 PM From: Barbara J Dawson on 10/10/200010:58 AM To: co: bcc: Subject: C8 Medical Sutveiilance - Draft Letter to Participants Last year, you participated In a baseline C8 m edical surveillance program which Included analysis of your blood for perfluorooctanoate (P F O A ) and total fluorine. You w ere asked to participate in this program because your job assignm ent at that tim e included the potential for exposure to C8. W e are n ow ready to c o n d u c t th e p o st cam paign su rve illa n ce . M edical will draw additional blood sam ples which will be analyzed for P F O A and total fluorine. T h ese results will be compared to your baseline results to determine if you received any exposure to th is chem ical during the past year. W e will share the results and interpretation o f the data with you. P le a se co n tact y o u r u n it S & O H coo rdin ato r to m ake arran gem en ts fo r an appointm ent at M edical. Stood will be drawn over the next few weeks on W ednesday. T hursday and Friday. Unit S & O H coordinators are: If you have any questions, please contact m e or your unit S& O H coordinator. SMUzod.DoesnofcoMaJn TSCACH 000224